|
Exicure, Inc. (XCUR) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Exicure, Inc. (XCUR) Bundle
¿Busca evaluar el valor intrínseco de Exicure, Inc.? Nuestra calculadora XCUR DCF integra datos del mundo real con opciones de personalización completas, lo que le permite ajustar los pronósticos y mejorar sus estrategias de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.3 | 16.6 | -.5 | 28.8 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 1181.87 | -102.91 | -6068.12 | -100 | -50 | -50 | -50 | -50 | -50 |
| EBITDA | -24.8 | -22.6 | -60.6 | .1 | -15.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -1913.04 | -136.33 | 12553.21 | 0.27059 | 100 | 0.05411781 | 0.05411781 | 0.05411781 | 0.05411781 | 0.05411781 |
| Depreciation | .7 | 1.4 | 1.8 | 1.9 | 1.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 55.86 | 8.71 | -368.32 | 6.44 | 100 | 14.2 | 14.2 | 14.2 | 14.2 | 14.2 |
| EBIT | -25.5 | -24.1 | -62.4 | -1.8 | -16.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -1968.9 | -145.04 | 12921.53 | -6.17 | 100 | -1.23 | -1.23 | -1.23 | -1.23 | -1.23 |
| Total Cash | 110.8 | 82.1 | 39.1 | 8.6 | .8 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 2.7 | 0.06621321 | 0 | 0 | 100 | 20.55 | 20.55 | 20.55 | 20.55 | 20.55 |
| Inventories | .0 | 3.0 | .0 | .5 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 18.24 | 0 | 1.77 | 100 | 24 | 24 | 24 | 24 | 24 |
| Accounts Payable | 1.8 | 1.9 | 3.4 | .4 | 1.6 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 139.97 | 11.23 | -706.63 | 1.25 | 100 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 |
| Capital Expenditure | -1.1 | -3.2 | -1.0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -83.49 | -19.09 | 200.41 | -0.0346909 | 100 | -20.52 | -20.52 | -20.52 | -20.52 | -20.52 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -25.5 | -24.1 | -62.4 | -1.9 | -16.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -24.1 | -28.8 | -57.0 | -3.7 | -13.8 | -1.6 | .0 | .0 | .0 | .0 |
| WACC, % | 10.23 | 10.23 | 10.23 | 10.23 | 10.23 | 10.23 | 10.23 | 10.23 | 10.23 | 10.23 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 6 | |||||||||
| Equity Value | -7 | |||||||||
| Diluted Shares Outstanding, MM | 8 | |||||||||
| Equity Value Per Share | -0.91 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Exicure, Inc.’s (XCUR) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Exicure, Inc. (XCUR).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Exicure, Inc. (XCUR).
- Interactive Dashboard and Charts: Visual representations highlight key valuation metrics for straightforward analysis.
How It Works
- 1. Download the Template: Get the Excel file containing Exicure, Inc.'s (XCUR) preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
- 3. View Instant Results: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Confidence: Deliver professional valuation insights to enhance your decision-making.
Why Choose This Calculator for Exicure, Inc. (XCUR)?
- Accuracy: Utilizes real Exicure financials for precise data representation.
- Flexibility: Tailored for users to easily adjust and experiment with inputs.
- Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive interface suitable for users with varying levels of financial modeling expertise.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments related to Exicure, Inc. (XCUR).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Exicure, Inc. (XCUR) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech companies like Exicure, Inc. (XCUR) are valued in the financial markets.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Exicure, Inc. (XCUR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models demonstrating intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate thorough analysis.
- Key Ratios: Incorporates profitability, leverage, and efficiency ratios for Exicure, Inc. (XCUR).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions for easy result analysis.